Factors that affect serum levels of ferritin in australian adults and implications for follow-up

Clinical Gastroenterology and Hepatology

Volumn 12, Issue 1, 2014, Pages 101-108.e4

  McKinnon, Elizabeth J ^a   Rossi, Enrico ^b   Beilby, John P ^b,c   Trinder, Debbie ^d,e   Olynyk, John K ^a,f,g  

^a MURDOCH UNIVERSITY   (Australia)

^b PATHWEST LABORATORY MEDICINE   (Australia)

^c UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^d UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^e UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^f FREMANTLE HOSPITAL   (Australia)

^g CURTIN UNIVERSITY   (Australia)

Author keywords

BMI; GGT; HOMA IR; Hyperferritinemia; Overweight; Population based Study; Risk Factor

Indexed keywords

ALANINE AMINOTRANSFERASE; BILIRUBIN; C REACTIVE PROTEIN; FERRITIN; GAMMA GLUTAMYLTRANSFERASE; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LIPID;

ADULT; AGED; ALKALINE PHOSPHATASE BLOOD LEVEL; ARTICLE; AUSTRALIA; BODY MASS; COMPARATIVE STUDY; ENZYME ACTIVITY; FEMALE; FERRITIN BLOOD LEVEL; FOLLOW UP; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; GLUCOSE BLOOD LEVEL; HUMAN; HUMAN TISSUE; INSULIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; OBESITY; POSTMENOPAUSE; PREMENOPAUSE; SEX DIFFERENCE; BLOOD; CHEMISTRY; MIDDLE AGED; REFERENCE VALUE; SERUM; YOUNG ADULT;

ADULT; AGED; AUSTRALIA; FEMALE; FERRITINS; HUMANS; MALE; MIDDLE AGED; REFERENCE VALUES; SERUM; YOUNG ADULT;

EID: 84890176372     PISSN: 15423565     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cgh.2013.07.019     Document Type: Article

References (27)

1. Clark S.F. Iron deficiency anemia: diagnosis and management. Curr Opin Gastroenterol 2009, 25:122-128.
2. Rossi E., Bulsara M.K., Olynyk J.K., et al. Effect of hemochromatosis genotype and lifestyle factors on iron and red cell indices in a community population. Clin Chem 2001, 47:202-208.
3. Pasricha S.R., Flecknoe-Brown S.C., Allen K.J., et al. Diagnosis and management of iron deficiency anaemia: a clinical update. Med J Aust 2010, 193:525-532.
4. Olynyk J.K. A population-based study of the clinical expression of the hemochromatosis gene. N Engl J Med 1999, 341:718-724.
5. Bell B. Australian Red Cross blood service referrals database 2012, Australian Red Cross, Alexandria, New South Wales, Australia.
6. Goot K., Hazeldine S., Bentley P., et al. Elevated serum ferritin: what should GPs know?. Aust Fam Physician 2012, 41:945-949.
7. Kowdley K.V., Belt P., Wilson L.A., et al. Serum ferritin is an independent predictor of histologic severity and advanced fibrosis in patients with nonalcoholic fatty liver disease. Hepatology 2012, 55:77-85.
8. Ayonrinde O.T., Milward E.A., Chua A.C., et al. Clinical perspectives on hereditary hemochromatosis. Crit Rev Clin Lab Sci 2008, 45:451-484.
9. Bacon B.R., Olynyk J.K., Brunt E.M., et al. HFE genotype in patients with hemochromatosis and other liver diseases. Ann Intern Med 1999, 130:953-962.
10. Pietrangelo A. Non-HFE hemochromatosis. Semin Liver Dis 2005, 450-460.
11. Olynyk J.K., Gan E., Tan T. Predicting iron overload in hyperferritinemia. Clin Gastroenterol Hepatol 2009, 7:359-362.
12. Guyader D., Jacquelinet C., Moirand R., et al. Noninvasive prediction of fibrosis in C282Y homozygous hemochromatosis. Gastroenterology 1998, 115:929-936.
13. Olynyk J.K., Trinder D., Ramm G.A., et al. Hereditary hemochromatosis in the post-HFE era. Hepatology 2008, 48:991-1001.
14. Allen K.J., Gurrin L.C., Constantine C.C., et al. Iron-overload-related disease in HFE hereditary haemochromatosis. N Engl J Med 2008, 358:221-230.
15. Beaton M.D., Adams P.C. Treatment of hyperferritinemia. Ann Hepatol 2012, 11:294-300.
16. Houschyar K.S., Ludtke R., Dobos G.J., et al. Effects of phlebotomy-induced reduction of body iron stores on metabolic syndrome: results from a randomized clinical trial. BMC Med 2012, 10:54.
17. Valenti L., Moscatiello S., Vanni E., et al. Venesection for non-alcoholic fatty liver disease unresponsive to lifestyle counseling: a propensity score-adjusted observational study. QJM 2011, 104:141-149.
18. Zacharski L.R., Chow B.K., Howes P.S., et al. Decreased cancer risk after iron reduction in patients with peripheral arterial disease: results from a randomized trial. J Natl Cancer Inst 2008, 100:996-1002.
19. Chalasani N., Younossi Z., Lavine J.E., et al. The diagnosis and management of non-alcoholic fatty liver disease: practice guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association. Hepatology 2012, 55:2005-2023.
20. Ioannou G.N., Dominitz J.A., Weiss N.S., et al. The effect of alcohol consumption on the prevalence of iron overload, iron deficiency, and iron deficiency anemia. Gastroenterology 2004, 126:1293-1301.
21. Knuiman M.W., Vu H.T. Prediction of coronary heart disease mortality in Busselton, Western Australia: an evaluation of the Framingham, national health epidemiologic follow up study, and WHO ERICA risk scores. J Epidemiol Community Health 1997, 51:515-519.
22. Knuiman M.W., Jamrozik K., Welborn T.A., et al. Age and secular trends in risk factors for cardiovascular disease in Busselton. Aust J Public Health 1995, 19:375-382.
23. Hung J., Knuiman M.W., Divitini M.L., et al. Prevalence and risk factor correlates of elevated C-reactive protein in an adult Australian population. Am J Cardiol 2008, 101:193-198.
24. Allen K.J., Bertalli N.A., Osborne N.J., et al. HFE Cys282Tyr homozygotes with serum ferritin concentrations below 1000 microg/L are at low risk of hemochromatosis. Hepatology 2010, 52:925-933.
25. Olynyk J.K., St Pierre T.G., Britton R.S., et al. Duration of hepatic iron exposure increases the risk of significant fibrosis in hereditary hemochromatosis: a new role for magnetic resonance imaging. Am J Gastroenterol 2005, 100:837-841.
26. Whitlock E.P., Garlitz B.A., Harris E.L., et al. Screening for hereditary hemochromatosis: a systematic review for the U.S. Preventive Services Task Force. Ann Intern Med 2006, 145:209-223.
27. Adams P.C., Reboussin D.M., Barton J.C., et al. Hemochromatosis and iron-overload screening in a racially diverse population. NEngl J Med 2005, 352:1769-1778.